BR0317925A - Utilização de uma molécula ativa, composição cosmética e processo de tratamento da celulite - Google Patents

Utilização de uma molécula ativa, composição cosmética e processo de tratamento da celulite

Info

Publication number
BR0317925A
BR0317925A BR0317925-7A BR0317925A BR0317925A BR 0317925 A BR0317925 A BR 0317925A BR 0317925 A BR0317925 A BR 0317925A BR 0317925 A BR0317925 A BR 0317925A
Authority
BR
Brazil
Prior art keywords
active molecule
treatment process
cosmetic composition
cellulite treatment
cellulite
Prior art date
Application number
BR0317925-7A
Other languages
English (en)
Inventor
Alain Geloun
Frederic Demarne
Catherine Girotti
Original Assignee
Gattefosse Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gattefosse Sas filed Critical Gattefosse Sas
Publication of BR0317925A publication Critical patent/BR0317925A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)

Abstract

"UTILIZAçãO DE UMA MOLéCULA ATIVA, COMPOSIçãO COSMéTICA E PROCESSO DE TRATAMENTO DA CELULITE". Utilização da molécula ativa de fórmula a seguir, com R = H ou R = glicose, para a fabricação de uma composição destinada a ativar a lipólise.
BR0317925-7A 2003-01-09 2003-12-30 Utilização de uma molécula ativa, composição cosmética e processo de tratamento da celulite BR0317925A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0300197A FR2849775B1 (fr) 2003-01-09 2003-01-09 Composition cosmetique a base de cirsimarine
PCT/FR2003/003938 WO2004069217A1 (fr) 2003-01-09 2003-12-30 Composition cosmetique a base de cirsimarine

Publications (1)

Publication Number Publication Date
BR0317925A true BR0317925A (pt) 2005-11-29

Family

ID=32524787

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317925-7A BR0317925A (pt) 2003-01-09 2003-12-30 Utilização de uma molécula ativa, composição cosmética e processo de tratamento da celulite

Country Status (8)

Country Link
US (1) US20060115502A1 (pt)
EP (1) EP1581178A1 (pt)
JP (1) JP2006514082A (pt)
AU (1) AU2003303900A1 (pt)
BR (1) BR0317925A (pt)
CA (1) CA2512275A1 (pt)
FR (1) FR2849775B1 (pt)
WO (1) WO2004069217A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1970051A1 (en) * 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
ITUD20080153A1 (it) 2008-06-26 2009-12-27 Biofarma S P A Composizione cosmetica, uso e relativo procedimento di produzione
JP2011148708A (ja) * 2010-01-19 2011-08-04 Noevir Co Ltd 保湿剤、抗老化剤、抗酸化剤、痩身剤、美白剤、抗炎症剤、免疫賦活剤、皮膚外用剤及び機能性経口組成物
US10039709B2 (en) * 2010-06-04 2018-08-07 Trilogic Pharma Llc Bioadhesive compositions for epithelial drug delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2233071A1 (en) * 1973-06-14 1975-01-10 Prod Hyg Laboratoires Flavones and saponins extracted from ivy - by solid-liquid extraction of undesirables followed by alcohol extraction
IT1233753B (it) * 1989-09-21 1992-04-14 Indena Spa Composizioni farmaceutiche ad attivita' sulla microcircolazione cutanea.
FR2742055B1 (fr) * 1995-12-12 1998-02-27 Ennagram Melange d'extraits de plantes et leurs utilisations, notamment pour le traitement local symptomatique des surcharges adipeuses sous-cutanees localisees
FR2778663B1 (fr) * 1998-05-15 2001-05-18 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
US6451837B1 (en) * 1999-09-01 2002-09-17 Andrius Baskys Neuroprotective effects of mitogen-activated protein kinase (MAPK) cascade inhibitors
US6444235B1 (en) * 1999-10-06 2002-09-03 Bioactiva Microtechne Canelo products and methods of making and using same
US20020106388A1 (en) * 2000-11-24 2002-08-08 Pugliese Peter T. Formulation of flavones and isoflavones for treatment of cellulite
EP1234572B1 (de) * 2001-02-26 2013-10-30 Mibelle AG Cosmetics Isoflavon-Aglykone enhaltende Hautbehandlungsmittel

Also Published As

Publication number Publication date
WO2004069217A1 (fr) 2004-08-19
FR2849775B1 (fr) 2005-02-11
EP1581178A1 (fr) 2005-10-05
AU2003303900A1 (en) 2004-08-30
US20060115502A1 (en) 2006-06-01
JP2006514082A (ja) 2006-04-27
FR2849775A1 (fr) 2004-07-16
CA2512275A1 (fr) 2004-08-19

Similar Documents

Publication Publication Date Title
BR0210941A (pt) Terapia de combinação de oxazolidinonas substituìdas
ATE468889T1 (de) Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
GB0223038D0 (en) Therapeutic compounds
GB0225474D0 (en) Therapeutic agents
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
SE0101387D0 (sv) Novel compounds
ATE498608T1 (de) Sulfone, die die aktivität von gamma-secretase modulieren
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BRPI0411534A (pt) derivados de lincomicina com atividade antimicrobiana
BR0315437A (pt) Composição para o tratamento dos cabelos, usos da mesma e método para o tratamento dos cabelos
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
DE60233350D1 (de) IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
SE0102147D0 (sv) New methods
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
RS8504A (en) Novel cyclohexil sulphones
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
BR0317925A (pt) Utilização de uma molécula ativa, composição cosmética e processo de tratamento da celulite
ATE464048T1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/7048 (2006.01), A61K 8/49 (2006.01), A61K